abstract |
The present invention relates to viral polymerase inhibitors of formula (I), their salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers, processes for their preparation and their use in the treatment of Use in Flaviviridae viral infection (eg Hepatitis C virus (HCV) infection). |